Company Profiles

driven by the PitchBook Platform

Hydra Biosciences

Description

Operator of a biopharmaceutical company developing drugs for the treatment of pain and inflammation. The company uses throughput screening platforms and integrated pharmacology to develop drugs for the treatment of renal disease, anxiety and pulmonary disease.

2001

Founded

PRIVATE

Status

11-50

Employees

Series E

Latest Deal Type

$11.5M

Latest Deal Amount

$95.7M

Total Amount Raised

Description

Operator of a biopharmaceutical company developing drugs for the treatment of pain and inflammation. The company uses throughput screening platforms and integrated pharmacology to develop drugs for the treatment of renal disease, anxiety and pulmonary disease.

Website:

www.hydrabiosciences.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

45 Moulton Street Cambridge, MA 02138United States +1 (617) 494-5230
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Hydra Biosciences's full profile, request a free trial.

Hydra Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Hydra Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Hydra Biosciences Investors (14)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Abbott LaboratoriesCorporationMinority000 0000000 0000
Abbott VenturesCorporate Venture CapitalMinority000 0000000 0000
Abingworth ManagementVenture CapitalMinority000 0000000 0000
Acceleration InternationalAccelerator/IncubatorMinority000 0000000 0000
Advanced Technology VenturesVenture CapitalMinority000 0000000 0000
Abbott Laboratories Corporation
Abbott Ventures Corporate Venture Capital
Abingworth Management Venture Capital
Acceleration International Accelerator/Incubator
Advanced Technology Ventures Venture Capital

Hydra Biosciences Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Russell HerndonPresident, Chief Executive Officer & Board Member
Thomas BurkeChief Financial Officer, Treasurer and Secretary
Mark Keating MDScientific Co-Founder and Member of Scientific Advisory Board
Magdalene Moran Ph.DSenior Vice President of Biology
Russell Herndon President, Chief Executive Officer & Board Member
Thomas Burke Chief Financial Officer, Treasurer and Secretary
Mark Keating MD Scientific Co-Founder and Member of Scientific Advisory Board
Magdalene Moran Ph.D Senior Vice President of Biology

Hydra Biosciences Board Members (9)

NameRepresentingRoleSinceContact
Info
Alan CranePolaris PartnersPartner & Entrepreneur000 0000
Jean GeorgeAdvanced Technology VenturesGeneral Partner000 0000
Karen Gotting-Smith Ph.DSelfBoard Member000 0000
Michael SanguinettiSelfBoard Member000 0000
Paul Goldenheim MDSelfBoard Member000 0000
Alan Crane Partner & Entrepreneur Polaris Partners
Jean George General Partner Advanced Technology Ventures
Karen Gotting-Smith Ph.D Board Member Self
Michael Sanguinetti Board Member Self
Paul Goldenheim MD Board Member Self
Request full access to PitchBook